Victory Capital Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $12.7M | Buy |
|
|||||
|
2025
Q2 | $1.35M | Buy |
|
|||||
|
2025
Q1 | $1.23M | Buy |
|
|||||
|
2024
Q4 | $1.11M | Buy |
|
|||||
|
2024
Q3 | $1.52M | Buy |
|
|||||
|
2024
Q2 | $891K | Buy |
|
|||||
|
2024
Q1 | $238K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $324K | Buy |
|
|||||
|
2022
Q2 | $283K | Buy |
|
|||||
|
2022
Q1 | $273K | Sell |
|
|||||
|
2021
Q4 | $460K | Sell |
|
|||||
|
2021
Q3 | $554K | Sell |
|
|||||
|
2021
Q2 | $26.1M | Buy |
|
|||||
|
2021
Q1 | $22.3M | Buy |
|
|||||
|
2020
Q4 | $21.8M | Buy |
|
|||||
|
2020
Q3 | $22.6M | Sell |
|
|||||
|
2020
Q2 | $25.2M | Buy |
|